Safety after extended repeated use of ulipristal acetate for uterine fibroids.
To assess long term safety of extended repeated 3-month courses of ulipristal acetate (UPA) 10 mg/day, for up to 8 courses, with focus on endometrial and laboratory safety parameters.This long-term, multi-center, open-label cohort, follow up study consisted of up to 8 consecutive 3-month courses of...
Main Authors: | Bart C J M Fauser, Jacques Donnez, Philippe Bouchard, David H Barlow, Francisco Vázquez, Pablo Arriagada, Sven O Skouby, Santiago Palacios, Janusz Tomaszewski, Boguslaw Lemieszczuk, Alistair R W William |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5340384?pdf=render |
Similar Items
-
Ulipristal acetate in uterine fibroids treatment
by: V V Korennaya, et al.
Published: (2013-12-01) -
Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis
by: Geale K, et al.
Published: (2017-11-01) -
Effects of ulipristal acetate in patients with symptomatic uterine fibroids
by: Natalia Navarro Plazaola, et al.
Published: (2021-05-01) -
Successful Pregnancy after Treatment with Ulipristal Acetate for Uterine Fibroids
by: Javier Monleón, et al.
Published: (2014-01-01) -
Empowering organ-preserving treatment of uterine fibroids using ulipristal acetate
by: A L Tikhomirov
Published: (2016-02-01)